Researchers tested the in vitro effect of different natural killer (NK)-cell engagers, which triggered either NKp46 or NKp30 together with CD16A, and targeted either CD19 or CD20 to induce killing of pediatric B cell precursor acute lymphoblastic leukemia.
[Cancer Immunology Research]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
172619
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
